| May-13-22 07:10AM |
Where Will Ocugen Be in 1 Year?The Motley Fool |
| May-09-22 07:05AM |
Could Novavax Stock Help You Retire a Millionaire?The Motley Fool |
| May-06-22 12:30PM |
Ocugen, Inc. (OCGN) Q1 2022 Earnings Call TranscriptThe Motley Fool |
| 07:45AM |
Ocugen (OCGN) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research |
| May-06-22 06:33AM |
Ocugen Provides Business Update and First Quarter 2022 Financial ResultsGlobeNewswire Inc. |
| May-02-22 07:37AM |
Ocugen to Host Conference Call on Friday, May 6 at 8:30 a.m. ET to Provide Business Update and Discuss First Quarter 2022 Financial ResultsGlobeNewswire Inc. |
| Apr-30-22 11:15AM |
2 Small-Cap Stocks With Monster Upsides, According to Wall StreetThe Motley Fool |
| Apr-29-22 11:36AM |
Ocugen, Inc. to Present Preclinical Results at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual MeetingGlobeNewswire Inc. |
| Apr-28-22 11:00AM |
Is It Too Late to Buy Ocugen Stock?The Motley Fool |
| 09:05AM |
The FDA Just Sent Ocugen a Warning. Should Investors Care?The Motley Fool |
| Apr-27-22 05:06AM |
3 Moonshot Stocks With Upside of Up to 709%, According to Wall StreetThe Motley Fool |
| Apr-25-22 07:33AM |
Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical TrialGlobeNewswire Inc. |
| Apr-19-22 05:32AM |
Ocugen, Inc. to Present at NobleCon18GlobeNewswire Inc. |
| 05:21AM |
4 Ultra-Popular Stocks to Avoid Like the PlagueThe Motley Fool |
| Apr-18-22 07:11AM |
Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North AmericaGlobeNewswire Inc. |
| Apr-17-22 11:30AM |
2 Red Flags for Ocugen's FutureThe Motley Fool |
| Apr-14-22 01:34AM |
Biotech Stock Roundup: SRRA Surges on GSK Buyout, HALO Offers Update & MoreZacks Investment Research |
| Apr-13-22 09:55AM |
Ocugen (OCGN) Stock Down as FDA Puts Hold on Covaxin StudyZacks Investment Research |
| Apr-12-22 08:31AM |
Ocugen, Inc. Provides Update on its Phase 2/3 Study of COVAXIN™ (BBV152)GlobeNewswire Inc. |
| Apr-06-22 05:21AM |
3 COVID-19 Stocks With Monster Upside of Up to 355%, According to Wall StreetThe Motley Fool |
| Apr-04-22 04:41AM |
Hot Biotech Penny Stocks to Watch During the First Full Week of April PennyStocks |
| Apr-01-22 11:19AM |
Why Ocugen Stock Is Jumping TodayThe Motley Fool |
| 07:37AM |
Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal DegenerationGlobeNewswire Inc. |
| Mar-30-22 05:06AM |
3 Growth Stocks With Monster Upside of Up to 331%, According to Wall StreetThe Motley Fool |
| Mar-26-22 07:00AM |
Is Johnson & Johnson Setting a Dangerous Precedent for the Healthcare Industry?The Motley Fool |
| Mar-24-22 11:37AM |
Is It Too Late to Buy Vaxart Stock?The Motley Fool |
| 05:56AM |
Is It Time to Buy COVID-19 Vaccine Stocks Again?The Motley Fool |
| Mar-23-22 07:44AM |
Ocugen Announces Appointment of Marna C. Whittington, PhD, to Board of DirectorsGlobeNewswire Inc. |
| Mar-21-22 06:36AM |
Ocugen, Inc. Appoints Jessica Crespo, CPA, to Chief Accounting Officer and Senior Vice President, FinanceGlobeNewswire Inc. |
| 08:43AM |
Here's what it will take to make stocks a 'great' buying opportunity, says this strategistMarketWatch |
| Mar-21-22 06:08AM |
Here's what it will take to make stocks a 'great' buying opportunityMarketWatch |
| 06:00AM |
1 Green Flag for Ocugen in 2022, and 1 Red FlagThe Motley Fool |
| Mar-18-22 05:56AM |
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire Inc. |
| Mar-17-22 08:10AM |
4 Numbers That Make Ocugen an Extremely Risky BuyThe Motley Fool |
| Mar-15-22 11:48AM |
Why Ocugen Stock Is Jumping TodayThe Motley Fool |
| 11:45AM |
Wall Street Thinks This Stock Could Soar by 242%; Here's Why It's Not a BuyThe Motley Fool |
| Mar-14-22 06:15AM |
Is It Too Late to Buy Ocugen Stock?The Motley Fool |
| Mar-11-22 11:23AM |
Is Ocugen Stock Heading for $0 After the FDA's Recent Decision?The Motley Fool |
| Mar-10-22 12:27PM |
The Zacks Analyst Blog Highlights Ocugen, Voyager Therapeutics, BioNTech, Regeneron and Gilead SciencesZacks Investment Research |
| Mar-09-22 12:54PM |
Biotech Stock Roundup: OCGN Down on Update, VYGR Surges on Deal & Other UpdatesZacks Investment Research |
| 08:20AM |
Is FDA Authorization for Novavax's Vaccine Imminent?The Motley Fool |
| Mar-09-22 07:11AM |
Ocugen, Inc. to Present at the 34th Annual ROTH ConferenceGlobeNewswire Inc. |
| 06:00AM |
Is There Any Hope for Ocugen?The Motley Fool |
| Mar-08-22 04:01AM |
Ocugen Fell Today: Is It a Buy Now?The Motley Fool |
| 11:51AM |
Why Ocugen Stock Is Falling TodayThe Motley Fool |
| Mar-08-22 05:06AM |
5 of the Fastest-Growing Stocks On the PlanetThe Motley Fool |
| Mar-04-22 11:42AM |
Why Ocugen Stock Is Crashing TodayThe Motley Fool |
| 07:01AM |
Ocugen Provides an Update on its COVAXIN™ Pediatric (2-18) Emergency Use Authorization (EUA) RequestGlobeNewswire Inc. |
| Mar-01-22 06:20AM |
Should You Invest in the SPDR S&P Biotech ETF (XBI)?Zacks Investment Research |
| Feb-28-22 12:40PM |
Why Ocugen Stock Is Jumping TodayThe Motley Fool |
4.29%
-0.0900
NameOcugen Inc
SectorHealthcare (1252)
IndustryBiotechnology (742)
Web
Phone484-328-4701
Employee16
Twitter
@Ocugen
SEC filings
Latest SEC Filings
Address5 Great Valley Parkway, Suite 160, Malvern, PA, United States (19355)